What Is Glutathione?

1. What does glutathione do in the body?

Your cells manufacture glutathione and recycle it. Enzymes called glutathione peroxidases use reduced glutathione, GSH, to help remove peroxides. This produces oxidized glutathione, GSSG. Another enzyme converts GSSG back to GSH using NADPH, a molecule that supplies the required electrons. Lu’s review of glutathione synthesis describes this cycle and its regulation.

Glutathione also participates in reactions that attach it to certain reactive compounds, helping the body process them. This chemistry is one reason it appears in “liver detox” advertising. Demonstrating faster clearance of a specific harmful substance would still require a treatment study measuring that substance and a relevant health outcome.

The phrase “master antioxidant” offers little help when comparing products. Glutathione operates within a network of enzymes, nutrients and cellular signals. Its normal biological role does not establish that pushing a blood value higher will improve health.

Like GHK-Cu, glutathione is a small peptide. Their shared size says little about their effects: the amino-acid sequence and chemistry differ.

2. Does oral glutathione work? The human trials

The claim that oral glutathione “cannot work because digestion destroys it” is too absolute. Human researchers have measured increases after oral supplementation. Results have also been inconsistent.

In the six-month Richie trial, the 1,000 mg group had mean increases of roughly 30–35% from baseline in red blood cells, plasma and lymphocytes. Levels generally returned to baseline after a month without supplementation. Those percentages describe concentrations in specific samples, not a 30–35% improvement in health.

The shorter Allen and Bradley trial used the same total daily amount as Richie’s higher-dose arm and found no significant benefit on its measured markers. Differences in duration, participants and methods may contribute, but comparing two separate trials cannot identify the cause. The evidence gives no basis for promising every user a response.

3. Liposomal vs regular glutathione vs IV

Liposomal formulations package glutathione with lipids. Micellar formulations use a different delivery structure. Both aim to change how the ingredient is handled after swallowing. “Reduced” describes the molecule’s chemical state; “liposomal” describes its formulation. A product can be both.

The Sinha pilot supports further testing of liposomal glutathione, but its 12 participants cannot establish superiority over ordinary capsules. Random assignment to two active doses does not supply the missing placebo or conventional-formulation comparison.

The 2026 Solnier crossover trial compared micellar glutathione at 300 mg, a liposomal formulation at 300 mg and standard glutathione at 500 mg. The micellar product produced about 2.49 times the baseline-adjusted blood exposure of the standard product at those administered doses. The often-quoted “up to fourfold” result came from dose-normalized calculations. Neither number measures a fourfold health benefit, and the micellar result cannot validate every product labeled liposomal.

An IV delivers material directly into circulation. That alone cannot establish better delivery to the relevant cells, longer-lasting effects or better health. Bioavailability and clinical effectiveness answer different questions. Oral doses also cannot be converted into an IV or subcutaneous protocol.

4. Glutathione vs NAC vs GlyNAC

N-acetylcysteine, or NAC, supplies a precursor to cysteine. GlyNAC combines NAC with glycine, providing two ingredients used to make glutathione. This approach depends on the body’s synthesis machinery and the availability of those ingredients.

Two randomized GlyNAC trials illustrate why the population and duration deserve attention:

The longer trial gives researchers a reason to investigate GlyNAC further. The larger short trial limits a blanket claim that all healthy older adults need more precursors. A subgroup identified after analyzing the results needs prospective testing before it can define who should take a supplement.

Neither trial compared GlyNAC directly with oral glutathione. They cannot establish which is “best,” prove that NAC alone reproduces the combination, or show that a healthy younger athlete will benefit. Changes in age-associated markers also do not measure years of life gained.

5. Glutathione for energy, exercise and recovery

There is some human exercise research, although the sample is small. In Aoi and colleagues’ 2015 crossover study, eight men took 1 g/day of glutathione or placebo for two weeks before a 60-minute cycling session. Researchers reported lower post-exercise lactate and improvements in fatigue-related questionnaire measures with glutathione.

The same paper included mouse experiments measuring muscle metabolism and mitochondrial markers. Those results should remain separate from the human findings. The men did not demonstrate a quantified increase in mitochondrial number, race performance or long-term training adaptation.

For someone tracking training, the unresolved questions are practical: does supplementation improve repeatable power, pace, strength or recovery across a training block? Eight participants and an acute cycling test cannot provide a dependable estimate. Research on another mitochondrial compound, such as MOTS-c, cannot fill that gap for glutathione.

6. Glutathione for skin pigmentation and aging

Weschawalit and colleagues’ 2017 trial compared oral reduced glutathione, oxidized glutathione and placebo over 12 weeks. Each active group received 250 mg/day. Pigmentation measurements generally trended lower with the active treatments, while some wrinkle measurements favored reduced glutathione. Results varied by outcome and body site.

This supplies limited evidence for effects on skin measurements. It does not establish a predictable number of shades of lightening, a permanent result after stopping or whole-body rejuvenation. The word “antiaging” in the paper’s title refers to skin properties measured during the trial; the study did not measure lifespan.

A trial of capsules also cannot establish the effectiveness or safety of a cosmetic IV drip. For before-and-after comparisons, changes in lighting, sun exposure, makeup and camera processing can all alter the apparent result. Standardized images are more informative than two differently lit selfies.

7. Glutathione dosage and how long it takes

Human oral studies discussed above used 250–1,000 mg/day over periods ranging from two weeks to six months. These amounts describe experiments. They do not establish a universal dose for fatigue, longevity or “detox,” and a higher dose does not guarantee a larger useful effect.

The time to detect a change depends on what was measured. A formulation study can detect a blood-exposure difference within a day; skin and physical-function studies require repeated observations over weeks. A blood result cannot predict when someone will feel different.

There is no validated injection cycle for general health improvement that follows from these oral trials. A half-life calculation also cannot supply one: circulating glutathione, intracellular stores and downstream effects follow different time courses.

8. Glutathione side effects and the 2026 IV warning

The small oral trials provide limited reassurance over their study periods. They cannot reliably detect uncommon reactions, establish safety over years or justify transferring their findings to injections. Safety also depends on the formulation, other ingredients and the person taking it.

On August 27, 2026, the FDA reported at least 30 patients with adverse events after compounded IV glutathione, given alone or with other ingredients. Reports included fever, chills, pain, dizziness and sepsis-like symptoms; some patients required hospitalization. The agency identified use of dietary supplement grade material and concerns about elevated endotoxins, bacterial components that can cause severe reactions.

That warning concerns injectable product quality. It does not show that ordinary oral glutathione caused those events. It does show why an ingredient suitable for a capsule is unsuitable evidence of injectable quality. Fever, shaking chills, difficulty breathing or faintness after an infusion warrant urgent medical assessment.

Inhalation has separate risks. Marrades and colleagues documented airway narrowing after nebulized glutathione in people with mild asthma. Tolerating an oral product does not predict tolerance by inhalation.

The FDA does not approve compounded drugs before marketing. A compounded prescription therefore does not mean the agency has reviewed that product’s safety, effectiveness or quality. Someone receiving cancer treatment, taking multiple medicines, pregnant or breastfeeding should discuss supplementation with their treating clinician; these general-wellness studies do not establish safety in those settings.

9. Can you test glutathione levels and track a useful result?

Laboratories can measure glutathione, but “my glutathione went up” needs context. Whole blood, plasma and red blood cells are different samples. Total glutathione, reduced GSH and the GSH/GSSG ratio are different measurements. Values from different methods are not interchangeable.

Sample handling can change the result before analysis. Giustarini and colleagues describe how glutathione can oxidize during sample preparation and distort the apparent balance between GSH and GSSG. A comparison should identify the laboratory, specimen, assay and collection conditions. The trials above do not establish a universal “optimal” number to chase.

For a personal record, define the intended outcome before buying a product. If the goal is cycling recovery, record a repeatable session and next-day fatigue. If it is skin appearance, use consistent photographs. Log the exact formulation, amount, dates, symptoms and simultaneous changes in sleep, diet, training or other supplements.

Starting glutathione, NAC and several peptides together makes any change difficult to attribute. A log can document what happened, but cannot remove expectation effects or replace a controlled trial. If the blood value changes while the outcome you care about does not, record both.

10. Glutathione FAQ

• What does glutathione do?

  Glutathione helps cells process peroxides, maintain the chemical state of proteins and handle certain reactive compounds. Cells make it from glutamate, cysteine and glycine. Those biological functions explain the research interest, but do not prove that extra glutathione improves every related health outcome.

• Does oral glutathione work?

  It can increase glutathione levels in some study settings. A six-month placebo-controlled trial found increases, while a four-week trial did not. Evidence for effects on everyday energy, recovery or disease prevention is much less established.

• Is liposomal glutathione better than regular glutathione?

  A small liposomal pilot found increased glutathione levels but had no placebo or standard-glutathione comparison. Formulation-specific absorption research does not establish that all liposomal products produce better health outcomes than ordinary capsules.

• Is NAC the same as glutathione?

  No. N-acetylcysteine supplies a precursor to cysteine, one of the amino acids used to make glutathione. GlyNAC combines NAC with glycine. Taking a precursor and taking the finished molecule are different interventions.

• How much glutathione did human studies use?

  The oral studies discussed here used 250 to 1,000 mg daily, depending on the formulation and question. These are research doses, not a universal recommendation. They cannot be converted into an injection schedule.

• Does glutathione lighten skin?

  Small oral trials have examined pigmentation, with results varying by measurement and body site. They do not establish a predictable shade change, permanent lightening or the safety and effectiveness of IV glutathione for cosmetic use.

• Does glutathione help with weight loss or longevity?

  The studies reviewed here do not establish a reliable fat-loss effect or longer human lifespan from glutathione supplementation. GlyNAC research in older adults measured metabolic and functional outcomes, but tested a different intervention.

• Are glutathione injections safe?

  Oral safety findings do not establish injectable safety. Compounded IV products have been linked to endotoxin-related adverse events, including hospitalizations. Fever, shaking chills, breathing difficulty or faintness after an infusion need urgent medical assessment.

11. Sources